about
Magnetic nanoparticle imaging by means of minimum norm estimates from remanence measurements.Certain types of iron oxide nanoparticles are not suited to passively target inflammatory cells that infiltrate the brain in response to strokeMagnetorelaxometry procedures for quantitative imaging and characterization of magnetic nanoparticles in biomedical applications.Magnetic Particle Spectroscopy Reveals Dynamic Changes in the Magnetic Behavior of Very Small Superparamagnetic Iron Oxide Nanoparticles During Cellular Uptake and Enables Determination of Cell-Labeling Efficacy.Biocompatibility of very small superparamagnetic iron oxide nanoparticles in murine organotypic hippocampal slice cultures and the role of microgliaThe influence of hydrodynamic diameter and core composition on the magnetoviscous effect of biocompatible ferrofluids.Magnetorelaxometry for localization and quantification of magnetic nanoparticles for thermal ablation studies.Quantification of magnetic nanoparticles by magnetorelaxometry and comparison to histology after magnetic drug targeting.Non-viral magnetic engineering of endothelial cells with microRNA and plasmid-DNA-An optimized targeting approach.Magnet-Bead Based MicroRNA Delivery System to Modify CD133+ Stem Cells.Efficient drug-delivery using magnetic nanoparticles--biodistribution and therapeutic effects in tumour bearing rabbits.Quantification and Localization of Extended Nanoparticle Distributions in Tissue Using Multipole Expansion.Quantitative reconstruction of a magnetic nanoparticle distribution using a non-negativity constraint.Preparation and In Vitro Characterization of Magnetized miR-modified Endothelial Cells.Phenomenological analysis of magnetic nanoparticle size distributions with temperature dependent magnetorelaxometry.Multi-color magnetic nanoparticle imaging using magnetorelaxometry.Magnetic particle spectroscopy allows precise quantification of nanoparticles after passage through human brain microvascular endothelial cells.Magnetic Nanoparticles Interact and Pass an In Vitro Co-Culture Blood-Placenta Barrier Model.Optimization of Iron Oxide Tracer Synthesis for Magnetic Particle Imaging.Intramyocardial fate and effect of iron nanoparticles co-injected with MACS® purified stem cell products.Magnetorelaxometric quantification of magnetic nanoparticles in an artery model after ex vivo magnetic drug targeting.Complex narrow band-pass filters for QRS detection in contactless magnetocardiograms of small animalsNoninvasive monitoring of blood flow using a single magnetic microsphereTargeted delivery of magnetic aerosol droplets to the lungMagnetized aerosols comprising superparamagnetic iron oxide nanoparticles improve targeted drug and gene delivery to the lungQuantitative imaging of magnetic nanoparticles by magnetorelaxometry with multiple excitation coilsMagnetic Particle Spectroscopy for the Quantification of Magnetic Nanoparticles in Living CellsTrack j: magnetic methods in medicineImproved sensitivity and limit-of-detection using a receive-only coil in magnetic particle imagingQuantitative 2D Magnetorelaxometry Imaging of Magnetic Nanoparticles using Optically Pumped MagnetometersMPI Phantom Study with A High-Performing Multicore Tracer Made by CoprecipitationVery small superparamagnetic iron oxide nanoparticles: Long-term fate and metabolic processing in atherosclerotic mice
P50
Q33374556-29AD5E42-D97A-427E-B4E0-DA774B06E188Q36839949-D053447B-D1DA-4658-AFAF-D07F14F0F388Q38600044-C76D68F9-102B-459C-AD69-4C2A2CF51343Q38764321-7730EA90-3A05-4D16-AA83-4CE1244BFF64Q38916303-D6FB7FC1-C51E-43FC-8DE0-B1F7D615F59DQ39212091-4C48FF3A-335B-4AE0-8378-025981672CA1Q39752310-E591A5A4-18DA-48DB-BE16-10FD3DD16CD6Q40218720-4FE6574A-C08D-454B-97AC-A6FA806B722AQ40662681-A0E2B715-F945-4058-9D58-DF48A270E313Q41482927-C391A947-E54C-4174-B9F6-88413263E1AFQ44500945-37A17179-8679-43FC-9CEE-7025ED8C306AQ44725417-21026DCA-E66C-4FD0-B9A8-03FD09F691C5Q44877583-A5C760AC-86C5-49CA-B4DB-0426F4E28F85Q45867825-97D0AE90-066E-4B83-A6EA-C03A654BD9BEQ46082255-6F053C45-129E-4439-84BA-FDFB474AF373Q47983514-6AB3FD15-B36C-498D-8474-16FC250ACAC5Q48749717-FBD5807B-4D5E-4808-A7CD-A852EDBF96F7Q50002357-A28FB703-D961-4D0A-9D79-95AE466E9789Q52807105-48080BFA-3700-4B3B-A373-955480C23F75Q52839314-D408A94D-43ED-4B7F-885D-2C5CDF336764Q52908987-62C16BD9-77A5-49E8-919F-E90C853B3046Q56963525-8EC9B2B6-253F-4A63-9C3A-80E93AFB353EQ64067937-0D7BC2CF-4944-4B4D-B1CD-A51107323260Q81697790-4B0BA7B4-97E7-42B1-A203-3BA70DFA6E60Q83309987-61A10F1D-1C67-4C65-B3F1-1C768F0A02DDQ85808892-FAFCF46C-1E8D-4036-91C1-11245FD0F939Q85872987-DF24B511-775B-4EF1-9244-E6DB481579B1Q85939859-439E65BF-751C-48F5-9899-836A04D46C4CQ89059489-0F38ACA6-CA45-4FA5-A521-276532342BFEQ89511592-2440BCC4-3CD7-491F-A62A-EA389A8333DEQ90774606-CBBAF97C-0337-42AC-BF46-9C4DAD2F7CC7Q91282688-E2019F6A-311F-4EC7-9767-CEDC33DF1CA9
P50
description
forsker
@nb
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
F. Wiekhorst
@ast
F. Wiekhorst
@nl
Frank Wiekhorst
@en
Frank Wiekhorst
@es
Frank Wiekhorst
@nb
type
label
F. Wiekhorst
@ast
F. Wiekhorst
@nl
Frank Wiekhorst
@en
Frank Wiekhorst
@es
Frank Wiekhorst
@nb
altLabel
F. Wiekhorst
@en
prefLabel
F. Wiekhorst
@ast
F. Wiekhorst
@nl
Frank Wiekhorst
@en
Frank Wiekhorst
@es
Frank Wiekhorst
@nb
P106
P108
P21
P31
P496
0000-0003-0608-1473